2007
DOI: 10.1007/s00436-007-0736-z
|View full text |Cite
|
Sign up to set email alerts
|

Differences in protein profiles of the isolates of Entamoeba histolytica and E. dispar by surface-enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF MS) ProteinChip assays

Abstract: Surface-enhanced laser desorption ionization time of flight mass spectrometry (SELDI-TOF MS) ProteinChip assays with weak cationic exchange chips were used for protein profiling of different isolates of Entamoeba histolytica and E. dispar. When SELDI-TOF MS spectra of cell lysates from E. histolytica strain HM-1:IMSS were compared with those from four other laboratory strains (200:NIH, HK-9, DKB, and SAW755CR) grown under the same culture conditions, different peak patterns of SELDI-TOF MS were observed among … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2008
2008
2019
2019

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 29 publications
0
3
0
Order By: Relevance
“…A previous study [ 25 ] used a different mass spectrometry technique (Surface-enhanced laser desorption ionization-Time of Flight—SELDI-TOF MS- Protein Chip assay) to analyze different isolates of E . histolytica and E .…”
Section: Discussionmentioning
confidence: 99%
“…A previous study [ 25 ] used a different mass spectrometry technique (Surface-enhanced laser desorption ionization-Time of Flight—SELDI-TOF MS- Protein Chip assay) to analyze different isolates of E . histolytica and E .…”
Section: Discussionmentioning
confidence: 99%
“…Whereas E. histolytica can produce intestinal and extra-intestinal lesions in humans, E. dispar is present in nonsymptomatic carriers. The distinction between the two species has been achieved through a combination of biochemical, immunological, and genetic data (Ackers et al 1997;Makioka et al 2007). As a consequence, our understanding of the epidemiology, control, and treatment of human amebiasis has changed.…”
Section: Introductionmentioning
confidence: 98%
“…Mass spectrometry can be used to search for biomarkers in the body fluids [8,9] of patients with diseases such as Chagas disease (Trypanosoma cruzi) [16] and Entamoeba histolytica infection [15], as well as in rheumatoid arthritis screening [12] and cancer research [1,9,12,27]. Mass spectrometry has many advantages, including high sensitivity, short duration from sample collection to diagnosis, potential for high-throughput screening, and a requirement for only small biological samples [10].…”
Section: Introductionmentioning
confidence: 99%